Take your 'sieg heil' and shove it up your ass. Resorting

New Post Public Reply Private Reply Replies (2) Message Board
Bhawks wowhappens28 #2435
139
Take your 'sieg heil' and shove it up your ass. Resorting to the Nazi card is always the sign of a meritless argument.

I'm on an aggressive Statin (Atorvastatin 80mg) regimen, so spare me your anecdotes.

Did you friend tell you that the doctor told HIM that the heart attack was DUE to cholesterol that was too low?

Quote:
Do statins really age you faster?

On Sunday the Express front page warned us that ‘statins age you faster’. But what does the research really show?




Suzi Gage



Monday 28 September 2015 01.30 EDT Last modified on Wednesday 20 September 2017 14.42 EDT


A lot of people are on statins. The British Heart Foundation state on their website that they are the most commonly prescribed drug in the UK. They’re taken predominately by middle aged men, some who have already suffered heart problems, and some who haven’t but fit in to an ‘at risk’ category that predicts cardiovascular disease.

But there are often scare stories around statins (I’ve written about this before), perhaps because they’re so widely prescribed, so it can be hard to work out what’s really known, or not known about them.

On Sunday, the Express’ front page claimed that ‘Statins age you faster’. The study it was referring to was published in July this year in the journal Cell Physiology. The research involved taking fat tissue biopsies from healthy people and extracting stem cells, and then exposing the stem cell samples to one of two types of statin. Stem cells are special cells that are found in fat tissue (and various other tissues), that can differentiate in to a variety of other specific types of cells, and are involved in tissue repair in adults.

The researchers found that the stem cells exposed to statins changed in to immune cells at lower levels than those that weren’t exposed to statins. The authors think this might be beneficial to the prevention of cardio-vascular disease, as there’s some suggestion that lower levels of these immune cells are associated with less inflammation in patients with cardio-vascular disease.

But the authors also studied how long it took each sample to double in proliferation, and noted that the statin treated samples grew more slowly, which they suggest could be linked to premature aging.

So, while these findings are interesting and potentially important, there’s quite a large leap from these studies of minced fat cells to the conclusion that being treated with statins will lead a person to age prematurely.

Science doesn’t yet fully understand what mechanisms at a cellular level cause aging. Stem cell proliferation speed is associated with aging. However, it is not the only mechanism that has been shown to be, and which ones are causal has not really been determined.


Interestingly, another study recently reported that statins could slow aging, as they were found to be associated with longer telomere length.

Telomeres are the areas at the end of the chromosomes, 23 pairs of which contain the DNA in each cell in your body. They are areas of repetitive DNA, thought to protect the chromosome itself from deterioration, and their shortening has been associated with premature aging.

This study measured telomerase activity in the blood of people who were either undergoing statin treatment or were not, and found it was increased in those on statins. Telomerase activity is associated with longer telomeres.

Statins do have side effects, all medication does to some extent. And some of those side effects reported could also be deemed to be signs of premature aging. Memory loss and weakness or fatigue are both listed under ‘uncommon side effects’ on the NHS website.


But these are alongside a cautionary note, describing a study that found little evidence of a difference in side effect symptoms between people on statins and those given an inert placebo medication.

Given that statins are often prescribed at a time in someone’s life when they might feasibly be starting to experience some of the ‘symptoms’ of aging, it can be hard to tease out whether such changes are due to a medication or not.

Of course, it’s perfectly possible that statins can improve some biological functions associated with aging and worsen others. Any decision to prescribe a medication needs to weigh up the potential benefits and the potential harms, and should be a decision between a GP or consultant and a patient.

Headlines that extrapolate from one cell culture study and use causal language won’t make these decisions any easier and if anything are more likely to confuse patients and their physicians.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 116

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Wabi's $1.25B Valuation: A New Era for AI?

Updated Category News Views 71

A Major Milestone for Wabi Well, here we go—Wabi, the brainchild of Eugenia Kuyda, is stirring the pot with a massive $55 million funding round, pulling its valuation up to a hefty $1.25 billion. If you're raising eyebrows at that price tag, you’re not alone. It's a big number riding on an even bigger idea: that AI isn't just for solitary chats anymore, but for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 73

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
AGIBOT's Worken: A New Era in Robot Productivity

Updated Category News Views 31

Measuring Productivity Goes Beyond Manufacturing Robots aren't just assembly-line tools anymore. In Shanghai, AGIBOT dropped a bombshell at their Innovation Day event: the introduction of Worken, a framework that turns the spotlight on robots' real-world task performance over mere numbers on a production line. Breaking Down Worken Worken, a mash-up of 'Work' and 'Token,'...

Continue Reading
xTool X1: Redefining Laser Fabrication for Makers

Updated Category News Views 118

The Next Generation of Laser Fabrication Whenever a new gizmo hits the market, it's usually just an upgrade in disguise—faster, shinier, a touch more wattage. Not this time. xTool shook things up by rolling out the X1, a laser platform that gets what small businesses and makers truly crave: versatility and long-lasting potential. This bad boy does more than engrave; it...

Continue Reading
New Insurance Rules Limit Public Input Amid Controversy

Updated Category News Views 20

Insurance Rules Change the Game, Yet Again When the bureaucracy tightens its grip, consumers often pay the price. California's recent twist in insurance regulations does just that, taking a red pen to public involvement and paving the road for insurers to hike rates with less interference. A Peek Behind the Curtain This new maneuver by the Department of Insurance...

Continue Reading
HiTHIUM Powers Up Australia's Energy Storage Future

Updated Category News Views 85

Just imagine, folks, a slice of the energy world reshaping right under our feet in good ol' Australia. That's the buzz HiTHIUM sparked at All Energy Australia as they showcased their fancy ?Power 6.9MWh, 8-hour long-duration battery storage system (BESS). It wasn’t just about the tech superiority but the strategic planting of stakes in the local energy market....

Continue Reading
Infinite Electronics Reveals Cutting-Edge Connectivity at Electronica

Updated Category News Views 143

Infinite Electronics Makes Waves at Electronica 2026 Let’s get down to brass tacks: Infinite Electronics is setting up one heck of a show at the electronica 2026 in Munich from November 10–13. They're not just there to give out free pens—these guys mean business with connectivity products that cover everything from drones to industrial automation. A Showcase of...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 67

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
Montage Partners Maintains its Founder-Friendly Status

Updated Category News Views 96

A Streak That Speaks Volumes Did you catch the latest from Scottsdale? Montage Partners, that people-first private equity outfit, just notched its sixth straight year on Inc.'s Founder-Friendly Investors list. Not something you snag with a casual handshake or flimsy promises—this accolade is about real, boots-on-the-ground partnership. Apparently, 294 firms made the...

Continue Reading

Top 5 Most Recently Viewed Articles

Aker Horizons ASA Completes Major Share Transfer for Merger

Updated Category News Views 217

Aker Horizons ASA Completes Major Share Transfer for Merger In a notable development, Aker Horizons ASA has taken a significant step toward advancing its planned merger with Aker Horizons Holding AS. This merger aims to consolidate resources and streamline operations, fostering a more robust operational model. Transfer of Shares Recently, Aker Capital AS successfully...

Continue Reading
Coppernico Unveils Promising Copper Drill Results at Sombrero

Updated Category News Views 111

Coppernico Reports Early Success in Drill Program Coppernico Metals Inc. is excited to share updates regarding its first drilling initiative at the Sombrero Project in Peru. With the company's commitment to exploring and developing significant copper-gold deposits, recent holes drilled at the site have provided promising initial results. Results from Initial Drilling The...

Continue Reading
Array Digital Infrastructure Thrives in Record-Setting Quarter

Updated Category News Views 205

Array Digital Infrastructure Reports Strong Growth in Third Quarter Array Digital Infrastructure, Inc. (NYSE: AD) has announced remarkable results for the third quarter of 2025, capturing attention with impressive financial performance. The company's operating revenues soared to $47.1 million, reflecting a significant increase from the $25.7 million reported during the...

Continue Reading
Nuveen Multi-Market Income Fund (JMM) Surges to New Heights

Updated Category News Views 45

Nuveen Multi-Market Income Fund (JMM) Hits 52-Week High In a thriving market environment, the Nuveen Multi-Market Income Fund (JMM) achieved a remarkable 52-week high of $6.43. This milestone signifies notable performance over the past year, with an impressive one-year change of 15.01%. Investor confidence in JMM has notably increased, as its income-generating investment...

Continue Reading
Maxeon Solar's Strategic Shift: Emphasizing U.S. Operations

Updated Category News Views 111

Maxeon Solar's New Direction in the U.S. Market Maxeon Solar Technologies (NASDAQ: MAXN), a prominent player in the solar panel industry, has announced a major shift in its operational strategy, directing its focus solely on the U.S. market. This decision is rooted in the company’s recognition of its strong presence and impending capabilities in local manufacturing,...

Continue Reading